CAS 1422171-08-1

Formule : C31H30N2O4

InChI : InChI=1S/C31H30N2O4/c1-18-10-12-25(19(2)14-18)30(23-8-6-5-7-9-23)32-28(34)16-22-11-13-26-24(15-22)17-27(36-26)31(35)29-20(3)33-37-21(29)4/h5-15,17,30-31,35H,16H2,1-4H3,(H,32,34)/t30-,31+/m0/s1

Code InChI : DIURRJOJDQOMFC-IOWSJCHKSA-N

SMILES : CC1=CC(=C(C=C1)[C@H](C2=CC=CC=C2)NC(=O)CC3=CC4=C(C=C3)OC(=C4)[C@H](C5=C(ON=C5C)C)O)C

TMP-778

CAS : 1422171-08-1

TMP-778

Formule : C₃₁H₃₀N₂O₄

Degré de pureté : 99.5%

Masse moléculaire : 494.58

Ref: 54-BUP21515

TMP-778

CAS : 1422171-08-1

TMP-778 is a selective inverse agonist of RORγt.

Formule : C₃₁H₃₀N₂O₄

Degré de pureté : 99.68%

Couleur et forme : Solid

Masse moléculaire : 494.58

Ref: TM-T13172L1

TMP-778

CAS : 1422171-08-1

Formule : C₃₁H₃₀N₂O₄

Degré de pureté : 97%

Masse moléculaire : 494.5809

Ref: IN-DA01X6GE

TMP 778

CAS : 1422171-08-1

TMP 778 is a molecule that induces the transfer of retinoic acid to the brain. It has been shown to have chemokine-like activity, but its precise mechanism of action is unknown. TMP 778 has been used in mice with inflammatory bowel disease and colitis as a therapeutic agent for these diseases. The drug is thought to be effective by preventing the expansion of Th17 cells, which are critical for the pathogenesis of intestinal inflammatory diseases. TMP 778 is not fully understood and further research is needed.

Formule : C₃₁H₃₀N₂O₄

Degré de pureté : Min. 95%

Masse moléculaire : 494.58 g/mol

Ref: 3D-FT174923